Journal for ImmunoTherapy of Cancer (Nov 2021)

485 Long term results from a phase 1 trial of GEN-009, a personalized neoantigen vaccine, combined with PD-1 inhibition in advanced solid tumors

  • Thomas Davis,
  • Jessica Price,
  • Mark Awad,
  • Ammar Sukari,
  • Roger Cohen,
  • Mark Stein,
  • Przemyslaw Twardowski,
  • Jessica Flechtner,
  • Melissa Johnson,
  • Maura Gillison,
  • Rudy Lackner,
  • Arthur DeCillis,
  • Richard Hernandez,
  • Kevin Mancini,
  • Mara Shainheit,
  • Gabriella Santone,
  • Syukri Shukor,
  • Ece Bicak,
  • Vijetha Vemulapalli,
  • Emily Tjon

DOI
https://doi.org/10.1136/jitc-2021-SITC2021.485
Journal volume & issue
Vol. 9, no. Suppl 2

Abstract

Read online

No abstracts available.